Amidst all this, these stocks that were seen trading below Rs 100 have delivered a standout performance. So, here are the top gainers from the list of the stocks that are listed below Rs 100.   

With 18 letters of intent (LoIs) and 24 memorandum of understanding (MoUs) involving an investment of around Rs 40,000 crore, the state signs off in style from World Expo, Dubai. These investments are proposed in various sectors such as tourism, logistics, petroleum, agri & food processing, e-waste recycling & energy, IT, real estate, etc.  

Chemical stocks have attracted quite a bit of attention in the last one month or so due to sharp profit booking witnessed in these stocks.

Next week will be a decisive week as the monthly contracts will expire and high volatility is expected. We suggest you to watch out for these crucial levels as Nifty Bank shows no signs of reversal.  

Next week will be a decisive week as the monthly contracts will expire and high volatility is expected.

Want to check long-term trend action? Nothing better than looking for a Golden Crossover. In this article, we have listed the top Nifty 500 stocks with golden crossover.

This continuous trend of growing profitability is very evident in the third consecutive quarter, where the net profit grew by 190 per cent QoQ all the way to Rs 58 lakh from Rs 20 lakh

Reducing our carbon footprint and increasing investment in logistics-related infrastructure are some of the expectations of Ishaan Gupta, Joint Managing Director, Gateway Distriparks Limited from the National Logistics Policy. 

F&O cues are suggesting 18,000 to act as a strong resistance for next week for Nifty 50.

Zydus Cadila has received final approval from the USFDA to market Nelarabine Injection 250MG/50ML in the United States. Zydus Pharmaceuticals USA Inc (Zydus) was granted a Competitive Generic Therapy (CGT) designation for Nelarabine Injection, Single-Dose Vial.